VIVO - メリディアン・バイオサイエンス (Meridian Bioscience Inc.)


   Meridian Bioscience rises 5% on boosted fiscal 2022 guidance  2022/02/04 17:13:47 Seeking Alpha
Meridian Bioscience <> rose following its Q1 results and a raised fiscal 2022 guidance.The company said net revenues in Q1 fiscal were $88.3M, only 5% below the record $92.9M in
   Meridian Bioscience Q1 2022 Earnings Preview  2022/02/03 18:20:27 Seeking Alpha
Meridian Bioscience (NASDAQ:VIVO) is scheduled to announce Q1 earnings results on Friday, February 4th, before market open.The consensus EPS Estimate is $0.27 (-52.6% Y/Y) and the
   GTS Sells SP5 Portfolio Company Comprising 2,115 Towers  2022/02/01 22:59:00 Kwhen Finance
   Meridian awarded additional NIH funding to advance development of Revogene panel  2022/01/31 17:12:53 Seeking Alpha
Meridian Bioscience <> announced that the National Institute of Health ((NIH)) awarded an additional $2.5M worth of funding to accelerate the development of its Revogene
   Meridian Bioscience launches saliva-specific mixes for DNA, RNA detection  2022/01/28 15:19:47 Seeking Alpha
Meridian Bioscience <> launched two master mixes that detect DNA and RNA in crude saliva samples.The company said the two new mixes, Lyo-Ready Direct DNA qPCR Saliva Mix…
   Vivo Y51A ,   2021/06/28 09:01:09 Maharashtra Times
Vivo Y51A , . Vivo India - , .
   Vivo Y51A 6GB ,   2021/06/28 08:46:58 NBT Hindi News
, 11, 5000 Vivo Y51A
   50 iPhone 11, Mi 10, OnePlus 9 5   2021/06/28 01:46:53 NBT Hindi News
50 Apple iPhone 11, Samsung Galaxy S20 FE 5G, OnePlus 9, Vivo X60 Pro Xiaomi Mi 10 5 , ,
   Vivo X60T Pro+ 50 MP 55W , X60 Pro+ ?  2021/06/28 00:43:43 NBT Hindi News
Vivo Vivo S60 Series Vivo X60T Pro+ , Vivo X60 Pro+
   5   2021/06/27 19:05:57 218TV
5 Vivo X60t Pro Plus. Snapdragon 888 Adreno 660 Android 11 Origin OS 1.0. AMOLED 6.56 FHD Plus 2376*1080 The post 5 appeared first on 218 .
   VIVO Cannabis™ Announces Closing of $8 Million Overnight Marketed Public Offering Including Full Exercise of Over-Allotment Option  2021/02/26 14:59:00 Cision (Canada)
/CNW/ - VIVO Cannabis Inc. (TSX: VIVO) ("VIVO" or the "Company") announced today the closing of its previously announced overnight marketed public offering…
   GI Stool Testing Market 2021 Leading Countries, Challenges, Five Forces Analysis, Trends, Drivers, Forecast to 2023 | BioMrieux Inc. Meridian Bioscience Inc. DiaSorin S.p.A. Beckman Coulter Inc. Alere Inc.  2021/02/24 14:07:51 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘GI Stool Testing Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The GI Stool Testing Market is expected to witness growth in upcoming years due to factors such as increase in
   Cannabis Stock Gainers And Losers From February 11, 2021  2021/02/11 22:24:49 Benzinga
GAINERS: MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 32.23% at $0.05 Pharmadrug (PINK: LMLLF ) shares closed up 5% $0.10 BioHarvest Sciences (PINK: CNVCF ) shares closed up 21.35% at$0.54 Abattis Bioceuticals (PINK: ATTBF ) shares closed up 17.65% at $0.04 Target Group (OTCQB: CBDY ) shares closed up 10.32% at $0.07 Meridian Bioscience (OTCQX: VIVO ) shares closed up 8.89% at $29.89 22nd Century Group, Inc. Common Stock (NYSEMKT: XXII ) shares closed up 7.16% at $3.74 Zelira Therapeutics (OTCQB: ZLDAF ) shares closed up 6.31% at $0.08 Teradyne (OTC: TER ) shares closed up 4.92% at $135.04 AusCann Group Holdings (PINK: ACNNF ) shares closed up 3.23% at $0.16 World Acceptance ( WRLD ) shares closed up 2.35% at $128.88 Full story available on
   Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day  2021/02/11 14:01:02 Yahoo Finance UK
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day
   John P. Kenny Sells 68,288 Shares of Meridian Bioscience, Inc. (NASDAQ:VIVO) Stock  2021/02/10 20:30:43 Watchlist News
Meridian Bioscience, Inc. (NASDAQ:VIVO) CEO John P. Kenny sold 68,288 shares of the stock in a transaction dated Monday, February 8th. The stock was sold at an average price of $29.86, for a total value of $2,039,079.68. Following the completion of the sale, the chief executive officer now directly owns 304,330 shares of the company’s […]